Long Protokol

Dyson JL, Kohler HG. Anencephaly and ovulation stimulation. Lancet. 1973;1(7814):1256-7.

James WH. Letter: Anencephaly, ovulation stimulation, and subfertility. Lancet. 1974;1(7870):1353.

Harlap S. Ovulation induction and congenital malformations. Lancet. 1976;2(7992):961.

Shoham Z, Zosmer A, Insler V. Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer. Fertil Steril. 1991;55(1):1-11.

Goss PE, Gwyn KM. Current perspectives on aromatase inhibitors in breast cancer. J Clin Oncol. 1994;12(11):2460-70.

Harvey HA. Aromatase inhibitors in clinical practice: current status and a look to the future. Semin Oncol. 1996;23(4 Suppl 9):33-8.

Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod. 2003;18(8):1588-97.

Taylor HS, Pal L, Seli E. Sectiov IV: Infertility: Assisted Reproduction Technologies In: Wilkins W, editor. Speroff’s Clinical gynecologic endocrinology and infertility. Philedelphia: Wolters Kluwer Health/ Lippincott; 2020. p. 2889-3046.

Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. Bmj. 2006;332(7556):1485.

Hrishikesh D. Pai PBG, Nandita P. Palshetkar, Rishma Dhillon, Pai. GnRH Agonists in Controlled Ovarian Stimulation. In: Ghumman. S, editor. Principles and

Practice of Controlled Ovarian Stimulation in ART: Springer; 2015.

Kayhan Yakın BU. Bölüm 33. Yardımcı Üreme Teknikleri. In: Çiçek MN, editor. Jinekolojik Endokrino-

loji ve İnfertilite El Kitabı. Ankara: Modern Tıp Kitabevi; 2018.

Filicori M, Cognigni GE, Pocognoli P, Ciampaglia W. Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze. Fertil Steril. 2003;80(5):1114-6.

Wiseman LR, Adkins JC. Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer. Drugs Aging. 1998;13(4):321-32.

Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril. 1987;48(6):958-63.

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group. Hum Reprod. 2000;15(7):1446-51.

Van Dorsselaer A, Carapito C, Delalande F, Schaeffer-Reiss C, Thierse D, Diemer H, et al. Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach. PLoS One. 2011;6(3):e17815.

Xi Q, Tao Y, Qiu M, Wang Y, Kuang Y. Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial. Clin Epidemiol. 2020;12:261-72.

Dyson JL, Kohler HG. Anencephaly and ovulation stimulation. Lancet. 1973;1(7814):1256-7.

James WH. Letter: Anencephaly, ovulation stimulation, and subfertility. Lancet. 1974;1(7870):1353.

Harlap S. Ovulation induction and congenital malformations. Lancet. 1976;2(7992):961.

Shoham Z, Zosmer A, Insler V. Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer. Fertil Steril. 1991;55(1):1-11.

Goss PE, Gwyn KM. Current perspectives on aromatase inhibitors in breast cancer. J Clin Oncol. 1994;12(11):2460-70.

Harvey HA. Aromatase inhibitors in clinical practice: current status and a look to the future. Semin Oncol. 1996;23(4 Suppl 9):33-8.

Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod. 2003;18(8):1588-97.

Taylor HS, Pal L, Seli E. Sectiov IV: Infertility: Assisted Reproduction Technologies In: Wilkins W, editor. Speroff’s Clinical gynecologic endocrinology and infertility. Philedelphia: Wolters Kluwer Health/ Lippincott; 2020. p. 2889-3046.

Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. Bmj. 2006;332(7556):1485.

Hrishikesh D. Pai PBG, Nandita P. Palshetkar, Rishma Dhillon, Pai. GnRH Agonists in Controlled Ovarian Stimulation. In: Ghumman. S, editor. Principles and

Practice of Controlled Ovarian Stimulation in ART: Springer; 2015.

Kayhan Yakın BU. Bölüm 33. Yardımcı Üreme Teknikleri. In: Çiçek MN, editor. Jinekolojik Endokrino-

loji ve İnfertilite El Kitabı. Ankara: Modern Tıp Kitabevi; 2018.

Filicori M, Cognigni GE, Pocognoli P, Ciampaglia W. Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze. Fertil Steril. 2003;80(5):1114-6.

Wiseman LR, Adkins JC. Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancer. Drugs Aging. 1998;13(4):321-32.

Abdalla HI, Ah-Moye M, Brinsden P, Howe DL, Okonofua F, Craft I. The effect of the dose of human chorionic gonadotropin and the type of gonadotropin stimulation on oocyte recovery rates in an in vitro fertilization program. Fertil Steril. 1987;48(6):958-63.

Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group. Hum Reprod. 2000;15(7):1446-51.

Van Dorsselaer A, Carapito C, Delalande F, Schaeffer-Reiss C, Thierse D, Diemer H, et al. Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach. PLoS One. 2011;6(3):e17815.

Xi Q, Tao Y, Qiu M, Wang Y, Kuang Y. Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial. Clin Epidemiol. 2020;12:261-72.